These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27809417)

  • 1. Design, synthesis, and biological evaluation of pyrimidine derivatives as potential inhibitors of human calcium/calmodulin-dependent protein kinase IV.
    Jameel E; Naz H; Khan P; Tarique M; Kumar J; Mumtazuddin S; Ahamad S; Islam A; Ahmad F; Hoda N; Hassan MI
    Chem Biol Drug Des; 2017 May; 89(5):741-754. PubMed ID: 27809417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure guided design of potential inhibitors of human calcium-calmodulin dependent protein kinase IV containing pyrimidine scaffold.
    Naz H; Jameel E; Hoda N; Shandilya A; Khan P; Islam A; Ahmad F; Jayaram B; Hassan MI
    Bioorg Med Chem Lett; 2016 Feb; 26(3):782-788. PubMed ID: 26783179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding studies and biological evaluation of β-carotene as a potential inhibitor of human calcium/calmodulin-dependent protein kinase IV.
    Naz H; Khan P; Tarique M; Rahman S; Meena A; Ahamad S; Luqman S; Islam A; Ahmad F; Hassan MI
    Int J Biol Macromol; 2017 Mar; 96():161-170. PubMed ID: 27956097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High throughput screening, docking, and molecular dynamics studies to identify potential inhibitors of human calcium/calmodulin-dependent protein kinase IV.
    Beg A; Khan FI; Lobb KA; Islam A; Ahmad F; Hassan MI
    J Biomol Struct Dyn; 2019 May; 37(8):2179-2192. PubMed ID: 30044185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, anticancer activity and docking studies of novel 4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives as mTOR inhibitors.
    Zhu W; Sun C; Xu S; Wu C; Wu J; Xu M; Zhao H; Chen L; Zeng W; Zheng P
    Bioorg Med Chem; 2014 Dec; 22(24):6746-54. PubMed ID: 25468038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of novel 3-substituted pyrazolopyrimidine derivatives as potent Bruton's tyrosine kinase (BTK) inhibitors.
    Zheng N; Pan J; Hao Q; Li Y; Zhou W
    Bioorg Med Chem; 2018 May; 26(8):2165-2172. PubMed ID: 29567295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pH on the structure, function, and stability of human calcium/calmodulin-dependent protein kinase IV: combined spectroscopic and MD simulation studies.
    Naz H; Shahbaaz M; Bisetty K; Islam A; Ahmad F; Hassan MI
    Biochem Cell Biol; 2016 Jun; 94(3):221-8. PubMed ID: 27032767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor.
    Hou J; Wan S; Wang G; Zhang T; Li Z; Tian Y; Yu Y; Wu X; Zhang J
    Eur J Med Chem; 2016 Aug; 118():276-89. PubMed ID: 27132165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design and synthesis of pyrimidine-4,6-diamine derivatives as Janus kinase 3 inhibitors.
    Yu RN; Chen CJ; Shu L; Yin Y; Wang ZJ; Zhang TT; Zhang DY
    Bioorg Med Chem; 2019 Apr; 27(8):1646-1657. PubMed ID: 30853331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Part-1: Design, synthesis and biological evaluation of novel bromo-pyrimidine analogs as tyrosine kinase inhibitors.
    Munikrishnappa CS; Puranik SB; Kumar GV; Prasad YR
    Eur J Med Chem; 2016 Aug; 119():70-82. PubMed ID: 27155464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hesperidin-CAMKIV interaction and its impact on cell proliferation and apoptosis in the human hepatic carcinoma and neuroblastoma cells.
    Naz H; Tarique M; Ahamad S; Alajmi MF; Hussain A; Rehman MT; Luqman S; Hassan MI
    J Cell Biochem; 2019 Sep; 120(9):15119-15130. PubMed ID: 31021496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrimidine-based pyrazoles as cyclin-dependent kinase 2 inhibitors: Design, synthesis, and biological evaluation.
    Vekariya MK; Vekariya RH; Brahmkshatriya PS; Shah NK
    Chem Biol Drug Des; 2018 Sep; 92(3):1683-1691. PubMed ID: 29767460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Potential Inhibitors of Calcium/Calmodulin-Dependent Protein Kinase IV from Bioactive Phytoconstituents.
    Gupta P; Khan S; Fakhar Z; Hussain A; Rehman MT; AlAjmi MF; Islam A; Ahmad F; Hassan MI
    Oxid Med Cell Longev; 2020; 2020():2094635. PubMed ID: 32724490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of pyrimidine derivatives as novel CDK2 inhibitors that induce apoptosis and cell cycle arrest in breast cancer cells.
    Wang Y; Chen Y; Cheng X; Zhang K; Wang H; Liu B; Wang J
    Bioorg Med Chem; 2018 Jul; 26(12):3491-3501. PubMed ID: 29853338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against Glioblastoma.
    Musumeci F; Fallacara AL; Brullo C; Grossi G; Botta L; Calandro P; Chiariello M; Kissova M; Crespan E; Maga G; Schenone S
    Eur J Med Chem; 2017 Feb; 127():369-378. PubMed ID: 28076826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel 2,4-disubstituted pyrimidines as Aurora kinase inhibitors.
    Xu Y; Hao SY; Zhang XJ; Li WB; Qiao XP; Wang ZX; Chen SW
    Bioorg Med Chem Lett; 2020 Feb; 30(3):126885. PubMed ID: 31862411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acridone-pyrimidine hybrids- design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies.
    Murahari M; Prakash KV; Peters GJ; Mayur YC
    Eur J Med Chem; 2017 Oct; 139():961-981. PubMed ID: 28886509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
    Bakr RB; Mehany ABM; Abdellatif KRA
    Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel crosstalk between calcium/calmodulin kinases II and IV regulates cell proliferation in myeloid leukemia cells.
    Monaco S; Rusciano MR; Maione AS; Soprano M; Gomathinayagam R; Todd LR; Campiglia P; Salzano S; Pastore L; Leggiero E; Wilkerson DC; Rocco M; Selleri C; Iaccarino G; Sankar U; Illario M
    Cell Signal; 2015 Feb; 27(2):204-14. PubMed ID: 25446257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, biological evaluation and molecular modeling of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRAF
    Wang Y; Wan S; Li Z; Fu Y; Wang G; Zhang J; Wu X
    Eur J Med Chem; 2018 Jul; 155():210-228. PubMed ID: 29886324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.